Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 123,110 shares at $114.94 ($14.2M) on 2020-05-12, disclosed to the SEC on 2020-05-14.
Open-market sale of $14.2M NBIX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.94 | 9,094 | $1.0M | 7.4% |
| 2 | $114.94 | 9,094 | $1.0M | 7.4% |
| 3 | $114.94 | 15,833 | $1.8M | 12.9% |
| 4 | $114.94 | 15,833 | $1.8M | 12.9% |
| 5 | $114.94 | 18,057 | $2.1M | 14.7% |
| 6 | $114.94 | 18,057 |
| $2.1M |
| 14.7% |
| 7 | $114.94 | 18,571 | $2.1M | 15.1% |
| 8 | $114.94 | 18,571 | $2.1M | 15.1% |
| Total | $114.94 avg | 123,110 | $14.2M | 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $537K | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |
| NBIX | SELL | 2020-02-11 | $335K | — | Filing → |